REVB Stock Analysis: Buy, Sell, or Hold?
REVB - Revelation Biosciences, Inc. Common Stock
$0.98
-0.05 (-4.92%)
▼
5d:
+2.01%
30d:
-18.39%
90d:
-33.38%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When REVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: REVB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: REVB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: REVB is currently trading at $0.98, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.20.
Technical Outlook: Technically, REVB is showing sideways momentum. Immediate support is located at $0.88, while resistance sits at $1.12. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: REVB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.25 (+1865.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, REVB is showing sideways momentum. Immediate support is located at $0.88, while resistance sits at $1.12. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: REVB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.25 (+1865.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.04 -
$1.20
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 1865.7% below Wall St target ($19.25)
Trading Range Analysis
30-Day Trading Range
$1.04 -
$1.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.88
Resistance Level
$1.12
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.35
Wall Street Target
$19.25
(+1865.7%)
Share & Embed Analysis
Last updated: May 18, 2026 8:37 AM ET
Data refreshes hourly during market hours. Next update: 9:37 AM
Data refreshes hourly during market hours. Next update: 9:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
